| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.34 | 0.04 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.04 |